Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Structure ; 26(6): 848-856.e3, 2018 06 05.
Article in English | MEDLINE | ID: mdl-29754826

ABSTRACT

The advent of direct electron detectors has enabled the routine use of single-particle cryo-electron microscopy (EM) approaches to determine structures of a variety of protein complexes at near-atomic resolution. Here, we report the development of methods to account for local variations in defocus and beam-induced drift, and the implementation of a data-driven dose compensation scheme that significantly improves the extraction of high-resolution information recorded during exposure of the specimen to the electron beam. These advances enable determination of a cryo-EM density map for ß-galactosidase bound to the inhibitor phenylethyl ß-D-thiogalactopyranoside where the ordered regions are resolved at a level of detail seen in X-ray maps at ∼ 1.5 Å resolution. Using this density map in conjunction with constrained molecular dynamics simulations provides a measure of the local flexibility of the non-covalently bound inhibitor and offers further opportunities for structure-guided inhibitor design.


Subject(s)
Thiogalactosides/pharmacology , beta-Galactosidase/chemistry , beta-Galactosidase/metabolism , Binding Sites , Cryoelectron Microscopy/methods , Crystallography, X-Ray , Drug Design , Models, Molecular , Molecular Dynamics Simulation , Protein Conformation
2.
Curr Opin Microbiol ; 43: 199-207, 2018 06.
Article in English | MEDLINE | ID: mdl-29656089

ABSTRACT

Over the past few years, the advances in technology and methods that have revolutionized cryo-EM are allowing for key insights in a variety of areas in biology, and microbiology is no exception. A wide range of important macromolecular assemblies in prokaryotic and eukaryotic cells, as well as intact viruses, have now become accessible to investigation by new methods in 3D electron microscopy. We focus here on selected examples that illustrate this breadth, and review the application of methods in single particle cryo-EM and cryo-electron tomography to progress in the structural biology of CRISPR systems, visualization of small molecule drugs in membrane proteins, in situ visualization of bacterial nanomachines, and the analysis of antigen-antibody interactions to drive vaccine design.


Subject(s)
Cryoelectron Microscopy/methods , Microbiological Techniques/instrumentation , Antigen-Antibody Complex/ultrastructure , Bacteria/ultrastructure , Cryoelectron Microscopy/instrumentation , Macromolecular Substances , Membrane Proteins/ultrastructure , Microbiological Techniques/methods , Nanoparticles/ultrastructure , Viruses/ultrastructure
3.
Cell ; 171(2): 414-426.e12, 2017 Oct 05.
Article in English | MEDLINE | ID: mdl-28985564

ABSTRACT

Prokaryotic cells possess CRISPR-mediated adaptive immune systems that protect them from foreign genetic elements, such as invading viruses. A central element of this immune system is an RNA-guided surveillance complex capable of targeting non-self DNA or RNA for degradation in a sequence- and site-specific manner analogous to RNA interference. Although the complexes display considerable diversity in their composition and architecture, many basic mechanisms underlying target recognition and cleavage are highly conserved. Using cryoelectron microscopy (cryo-EM), we show that the binding of target double-stranded DNA (dsDNA) to a type I-F CRISPR system yersinia (Csy) surveillance complex leads to large quaternary and tertiary structural changes in the complex that are likely necessary in the pathway leading to target dsDNA degradation by a trans-acting helicase-nuclease. Comparison of the structure of the surveillance complex before and after dsDNA binding, or in complex with three virally encoded anti-CRISPR suppressors that inhibit dsDNA binding, reveals mechanistic details underlying target recognition and inhibition.


Subject(s)
Bacterial Proteins/chemistry , CRISPR-Associated Proteins/chemistry , CRISPR-Cas Systems , Cryoelectron Microscopy , Pseudomonas aeruginosa/chemistry , Pseudomonas aeruginosa/immunology , Bacteriophages/genetics , Bacteriophages/immunology , CRISPR-Associated Proteins/immunology , CRISPR-Associated Proteins/ultrastructure , DNA, Viral/chemistry , Models, Chemical , Models, Molecular , Multiprotein Complexes/chemistry , Pseudomonas aeruginosa/metabolism , Pseudomonas aeruginosa/ultrastructure
4.
Nat Microbiol ; 2(10): 1415-1424, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28827718

ABSTRACT

A substantial proportion of influenza-related childhood deaths are due to infection with influenza B viruses, which co-circulate in the human population as two antigenically distinct lineages defined by the immunodominant receptor binding protein, haemagglutinin. While broadly cross-reactive, protective monoclonal antibodies against the haemagglutinin of influenza B viruses have been described, none targeting the neuraminidase, the second most abundant viral glycoprotein, have been reported. Here, we analyse a panel of five murine anti-neuraminidase monoclonal antibodies that demonstrate broad binding, neuraminidase inhibition, in vitro antibody-dependent cell-mediated cytotoxicity and in vivo protection against influenza B viruses belonging to both haemagglutinin lineages and spanning over 70 years of antigenic drift. Electron microscopic analysis of two neuraminidase-antibody complexes shows that the conserved neuraminidase epitopes are located on the head of the molecule and that they are distinct from the enzymatic active site. In the mouse model, one therapeutic dose of antibody 1F2 was more protective than the current standard of treatment, oseltamivir, given twice daily for six days.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , Epitopes , Influenza B virus/immunology , Neuraminidase , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Neutralizing/immunology , Antibodies, Viral/pharmacology , Antibodies, Viral/therapeutic use , Cross Reactions , Disease Models, Animal , Dogs , Female , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Influenza B virus/drug effects , Madin Darby Canine Kidney Cells , Mice , Mice, Inbred BALB C , Models, Molecular , Neuraminidase/analysis , Orthomyxoviridae Infections/drug therapy , Sf9 Cells , Viral Proteins/immunology
5.
Curr Opin Struct Biol ; 46: 71-78, 2017 10.
Article in English | MEDLINE | ID: mdl-28646653

ABSTRACT

The pace at which cryo-EM is being adopted as a mainstream tool in structural biology has continued unabated over the past year. Initial successes in obtaining near-atomic resolution structures with cryo-EM were enabled to a large extent by advances in microscope and detector technology. Here, we review some of the complementary technical improvements that are helping sustain the cryo-EM revolution. We highlight advances in image processing that permit high resolution structure determination even in the presence of structural and conformational heterogeneity. We also review selected examples where biochemical strategies for membrane protein stabilization facilitate cryo-EM structure determination, and discuss emerging approaches for further improving the preparation of reliable plunge-frozen specimens.


Subject(s)
Cryoelectron Microscopy/methods , Membrane Proteins/chemistry , Humans
6.
Curr Opin Struct Biol ; 41: 194-202, 2016 12.
Article in English | MEDLINE | ID: mdl-27552081

ABSTRACT

The prospect that the structures of protein assemblies, small and large, can be determined using cryo-electron microscopy (cryo-EM) is beginning to transform the landscape of structural biology and cell biology. Great progress is being made in determining 3D structures of biological assemblies ranging from icosahedral viruses and helical arrays to small membrane proteins and protein complexes. Here, we review recent advances in this field, focusing especially on the emerging use of cryo-EM in mapping the binding of drugs and inhibitors to protein targets, an application that requires structure determination at the highest possible resolutions. We discuss methods used to evaluate the information contained in cryo-EM density maps and consider strengths and weaknesses of approaches currently used to measure map resolution.


Subject(s)
Cryoelectron Microscopy/methods , Drug Discovery/methods , Animals , Humans , Ligands , Signal-To-Noise Ratio , Small Molecule Libraries/metabolism
7.
Cell ; 165(7): 1698-1707, 2016 Jun 16.
Article in English | MEDLINE | ID: mdl-27238019

ABSTRACT

Recent advances in single-particle cryoelecton microscopy (cryo-EM) are enabling generation of numerous near-atomic resolution structures for well-ordered protein complexes with sizes ≥ ∼200 kDa. Whether cryo-EM methods are equally useful for high-resolution structural analysis of smaller, dynamic protein complexes such as those involved in cellular metabolism remains an important question. Here, we present 3.8 Å resolution cryo-EM structures of the cancer target isocitrate dehydrogenase (93 kDa) and identify the nature of conformational changes induced by binding of the allosteric small-molecule inhibitor ML309. We also report 2.8-Å- and 1.8-Å-resolution structures of lactate dehydrogenase (145 kDa) and glutamate dehydrogenase (334 kDa), respectively. With these results, two perceived barriers in single-particle cryo-EM are overcome: (1) crossing 2 Å resolution and (2) obtaining structures of proteins with sizes < 100 kDa, demonstrating that cryo-EM can be used to investigate a broad spectrum of drug-target interactions and dynamic conformational states.


Subject(s)
Drug Discovery , Glutamate Dehydrogenase/ultrastructure , Isocitrate Dehydrogenase/ultrastructure , L-Lactate Dehydrogenase/ultrastructure , Aminoquinolines/chemistry , Aminoquinolines/pharmacology , Animals , Cattle , Chickens , Cryoelectron Microscopy , Crystallography, X-Ray , Glutamate Dehydrogenase/antagonists & inhibitors , Glutamate Dehydrogenase/chemistry , Humans , Isocitrate Dehydrogenase/antagonists & inhibitors , Isocitrate Dehydrogenase/chemistry , L-Lactate Dehydrogenase/antagonists & inhibitors , L-Lactate Dehydrogenase/chemistry , Models, Molecular , Protein Conformation , Sulfonamides/chemistry , Sulfonamides/pharmacology
8.
Mol Pharmacol ; 89(6): 645-51, 2016 06.
Article in English | MEDLINE | ID: mdl-27036132

ABSTRACT

Cryo-electron microscopy (cryo-EM) methods are now being used to determine structures at near-atomic resolution and have great promise in molecular pharmacology, especially in the context of mapping the binding of small-molecule ligands to protein complexes that display conformational flexibility. We illustrate this here using glutamate dehydrogenase (GDH), a 336-kDa metabolic enzyme that catalyzes the oxidative deamination of glutamate. Dysregulation of GDH leads to a variety of metabolic and neurologic disorders. Here, we report near-atomic resolution cryo-EM structures, at resolutions ranging from 3.2 Å to 3.6 Å for GDH complexes, including complexes for which crystal structures are not available. We show that the binding of the coenzyme NADH alone or in concert with GTP results in a binary mixture in which the enzyme is in either an "open" or "closed" state. Whereas the structure of NADH in the active site is similar between the open and closed states, it is unexpectedly different at the regulatory site. Our studies thus demonstrate that even in instances when there is considerable structural information available from X-ray crystallography, cryo-EM methods can provide useful complementary insights into regulatory mechanisms for dynamic protein complexes.


Subject(s)
Cryoelectron Microscopy/methods , Glutamate Dehydrogenase/ultrastructure , Animals , Cattle , Crystallography, X-Ray , Glutamate Dehydrogenase/chemistry , Guanosine Triphosphate/chemistry , Guanosine Triphosphate/metabolism , Ligands , Mammals , Models, Molecular , NAD/chemistry , NAD/metabolism , Protein Structure, Quaternary
9.
Science ; 351(6275): 871-5, 2016 Feb 19.
Article in English | MEDLINE | ID: mdl-26822609

ABSTRACT

p97 is a hexameric AAA+ adenosine triphosphatase (ATPase) that is an attractive target for cancer drug development. We report cryo-electron microscopy (cryo-EM) structures for adenosine diphosphate (ADP)-bound, full-length, hexameric wild-type p97 in the presence and absence of an allosteric inhibitor at resolutions of 2.3 and 2.4 angstroms, respectively. We also report cryo-EM structures (at resolutions of ~3.3, 3.2, and 3.3 angstroms, respectively) for three distinct, coexisting functional states of p97 with occupancies of zero, one, or two molecules of adenosine 5'-O-(3-thiotriphosphate) (ATPγS) per protomer. A large corkscrew-like change in molecular architecture, coupled with upward displacement of the N-terminal domain, is observed only when ATPγS is bound to both the D1 and D2 domains of the protomer. These cryo-EM structures establish the sequence of nucleotide-driven structural changes in p97 at atomic resolution. They also enable elucidation of the binding mode of an allosteric small-molecule inhibitor to p97 and illustrate how inhibitor binding at the interface between the D1 and D2 domains prevents propagation of the conformational changes necessary for p97 function.


Subject(s)
Adenosine Triphosphatases/antagonists & inhibitors , Adenosine Triphosphatases/chemistry , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/chemistry , Adenosine Diphosphate/chemistry , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/chemistry , Allosteric Regulation , Binding Sites , Cryoelectron Microscopy , Enzyme Inhibitors , Humans , Models, Molecular , Protein Structure, Tertiary
SELECTION OF CITATIONS
SEARCH DETAIL
...